Active Ingredient History
Maltodextrin is a polysaccharide that is used as a food ingredient. It is produced from vegetable starch by partial hydrolysis and is usually found as a white hygroscopic spray-dried powder. Maltodextrin is easily digestible, being absorbed as rapidly as glucose and may be either moderately sweet or almost flavorless. It can be found as an ingredient in a variety of processed foods. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 1/Phase 2)
Anemia, Sickle Cell (Phase 3)
Anxiety (Phase 2)
beta-Thalassemia (Phase 3)
Bone Diseases (Phase 1)
Bone Diseases, Endocrine (Early Phase 1)
Carcinoma, Hepatocellular (Phase 2)
Cardiovascular Diseases (Phase 2)
Central Serous Chorioretinopathy (Phase 2/Phase 3)
Colitis, Ulcerative (Early Phase 1)
Constipation (Phase 4)
COVID-19 (Phase 2/Phase 3)
Critical Illness (Phase 3)
Crohn Disease (Early Phase 1)
Depressive Disorder, Major (Phase 2)
Dermatitis, Atopic (Phase 3)
Diabetes Mellitus, Type 1 (Phase 1)
Diarrhea (Phase 2)
Diet Therapy (Phase 2)
Dyspepsia (Phase 1/Phase 2)
Endothelial Cells (Phase 2)
Enteral Nutrition (Phase 3)
Enteritis (Phase 3)
Fatigue (Phase 2)
Fibrosis (Phase 2)
Gastrointestinal Microbiome (Phase 2)
General Surgery (Phase 3)
Healthy Volunteers (Phase 4)
Heart Failure (Phase 1)
Hepatic Encephalopathy (Phase 4)
Infections (Phase 3)
Inflammation (Phase 3)
Insulin Resistance (Phase 3)
Intensive Care Units (Phase 2)
Intestinal Neoplasms (Phase 3)
Irritable Bowel Syndrome (Phase 3)
Kidney Diseases (Phase 2)
Liver Failure (Phase 2)
Metabolic Syndrome (Phase 1)
Mitochondrial Diseases (Phase 2)
Multiple Organ Failure (Phase 3)
Multiple Sclerosis (Phase 2)
Neonatal Sepsis (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 2)
Nutritional and Metabolic Diseases (Early Phase 1)
Obesity (Phase 2)
Overweight (Early Phase 1)
Pain (Phase 2)
Parkinson Disease (Phase 2)
Pediatric Obesity (Phase 3)
Pouchitis (Phase 1)
Prediabetic State (Phase 1)
Proctitis (Phase 3)
Prostatic Neoplasms (Phase 2/Phase 3)
Quality of Life (Phase 1)
Renal Insufficiency, Chronic (Phase 2)
Respiratory Aspiration (Phase 2)
Sarcopenia (Phase 2)
SARS-CoV-2 (Phase 2)
Sepsis (Phase 2)
Signs and Symptoms, Digestive (Phase 1/Phase 2)
Stomach Neoplasms (Phase 3)
Typhoid Fever (Early Phase 1)
Vaccines (Early Phase 1)
Vitamin D Deficiency (Early Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue